Titan Medical Inc. (TMDI)

NASDAQ: TMDI · IEX Real-Time Price · USD
+0.025 (4.96%)
Jul 1, 2022 1:31 PM EDT - Market open

Total Valuation

Titan Medical has a market cap or net worth of $59.79 million. The enterprise value is $30.92 million.

Market Cap 59.79M
Enterprise Value 30.92M

Important Dates

The next earnings date is Wednesday, August 10, 2022, before market open.

Estimated Earnings Date Aug 10, 2022
Ex-Dividend Date n/a

Share Statistics

Titan Medical has 112.19 million shares outstanding. The number of shares has increased by 178.65% in one year.

Shares Outstanding 112.19M
Shares Change (YoY) +178.65%
Shares Change (QoQ) +0.07%
Owned by Insiders (%) 0.11%
Owned by Institutions (%) 3.22%
Float 111.13M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.98
PB Ratio 2.24
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.54
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.05.

Current Ratio 4.04
Quick Ratio 3.80
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -31.00%, which is considered low.

Return on Equity (ROE) -31.00%
Return on Assets (ROA) -19.20%
Return on Capital (ROIC) n/a
Revenue Per Employee $409,041
Profits Per Employee -$189,490
Employee Count 49
Asset Turnover 0.42
Inventory Turnover n/a


In the past 12 months, Titan Medical has paid $56,000 in taxes.

Income Tax 56,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -68.84% in the last 52 weeks. The beta is 4.57, so Titan Medical's price volatility has been higher than the market average.

Beta (1Y) 4.57
52-Week Price Change -68.84%
50-Day Moving Average 0.49
200-Day Moving Average 0.55
Average Volume (30 Days) 234,342

Short Selling Information

The latest short interest is 383,330, so 0.34% of the outstanding shares have been sold short.

Short Interest 383,330
Short % of Shares Out 0.34%
Short % of Float 0.34%
Short Ratio (days to cover) 2.88

Income Statement

In the last 12 months, Titan Medical had revenue of $20.04 million and -9.29 million in losses. Earnings per share was -$0.08.

Revenue 20.04M
Gross Profit 20.04M
Operating Income -31.35M
Pretax Income -9.23M
Net Income -9.29M
EBIT -9.09M
Earnings Per Share (EPS) -$0.08
Full Income Statement

Balance Sheet

The company has $30.11 million in cash and $1.24 million in debt, giving a net cash position of $28.87 million or $0.26 per share.

Cash & Cash Equivalents 30.11M
Total Debt 1.24M
Net Cash 28.87M
Net Cash Per Share $0.26
Book Value 26.67M
Book Value Per Share 0.24
Working Capital 24.04M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.23 million and capital expenditures -$383,000, giving a free cash flow of -$25.62 million.

Operating Cash Flow -25.23M
Capital Expenditures -383,000
Free Cash Flow -25.62M
FCF Per Share n/a
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -156.42% and -46.33%.

Gross Margin 100.00%
Operating Margin -156.42%
Pretax Margin -46.05%
Profit Margin -46.33%
EBITDA Margin -41.49%
EBIT Margin -45.33%
FCF Margin -127.80%

Dividends & Yields

Titan Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -15.53%
FCF Yield -42.84%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Buy
Analyst Count 5
Stock Forecasts

Stock Splits

The last stock split was on June 19, 2018. It was a reverse split with a ratio of 1:30.

Last Split Date Jun 19, 2018
Split Type Reverse
Split Ratio 1:30